Cancer

Metformin significantly reduces insulin-like growth factor I levels after 3 to 6 months among cancer survivors with obesity, but the effect wanes over time, according to data published in The Journal of Clinical Endocrinology & Metabolism.

Obesity increases the risk for developing cancer at 10 different sites, regardless of which adiposity-related markers are used, according to data presented at the European Congress on Obesity annual meeting.

Among patients with cancer who experienced a stroke, reperfusion therapy conferred similar short-term outcomes as in patients with stroke and nonactive cancer or no history of cancer, researchers reported.

The U.S. Preventive Services Task Force announced that supplementation with vitamin E provides no benefit and the harms of beta-carotene supplementation outweigh any benefits for the prevention of CVD and cancer.

Middle-aged men who are lonely had increased risk for cancer, regardless of the social network size, according to results of a longitudinal study published in Psychiatry Research.

Researchers confirmed the long-term oncological safety of laparoscopic surgery was comparable to the long-term safety of open surgery in patients with rectal cancer, according to The Lancet Gastroenterology and Hepatology.

A survey revealed that depression has increased among U.S. adults with cancer during the pandemic. A review of treatment interventions and the potential benefits of pharmacogenetic testing was the top story in hematology/oncology last week.

In this video, Debu Tripathy, MD, professor and chair of the department of breast medical oncology at The University of Texas MD Anderson Cancer Center and HemOnc Today Editorial Board member, discussed the exciting potential of antibody drug conjugates.

GI OnDEMAND has recently partnered with Ambry Genetics to integrate online genetic counseling and testing services into gastroenterology practices in the United States to better identify hereditary gastrointestinal cancer syndromes.

CV risk factors such as age, sex, smoking status, 10-year atherosclerotic CVD risk and certain biomarkers were independently associated with risk for future cancer, according to data published in JACC: CardioOncology.